Lariciresinol

Overview

Lariciresinol is an orally active ingredient. Lariciresinol can be isolated from Arabidopsis thaliana . Lariciresinol inhibits α-glucosidase activity ( IC 50 of 6.97 μM; K i of 0.046 μM). Lariciresinol dereases Bcl-2 , upregulates Bax and induces Apoptosis . Lariciresinol regulates TGF-β and NF-κB pathways. Lariciresinol has antitumor activity against liver cancer , gastric cancer , and breast cancer . Lariciresinol shows antifungal activity and anti-diabetic activity.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > TGF-β Receptor | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Fungal | Products > Signaling Pathways > Glycosidase | Products > Signaling Pathways > Bcl-2 Family | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-N3405
• CAS No.: 27003-73-2
• Molecular Formula: C20H24O6
• Molecular Weight: 360.40
• Purity: 99.46%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Availability: In-stock

Source

Original product source